Ofatumumab Active Not Recruiting Phase 4 Trials for Relapsing Multiple Sclerosis (RMS) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT05199571Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China